- Record: found
- Abstract: found
- Article: found
ELAT Study (Embolism in Left Atrial Thrombi): Baseline Clinical and Echocardiographic Data
Abstract
By transesophageal echocardiography, the prevalence of left atrial/appendage thrombi and spontaneous echo contrast and the size of the left atrial appendage and their association with clinical and echocardiographic characteristicswere evaluated in 409 nonrheumatic atrial fibrillation outpatients (62 ± 12years) without recent ( < 1 year) embolism. Left atrial/appendage thrombi (2.5%) were associated with diabetes (p < 0.05), heart failure (p < 0.05) and low fractional shortening (p < 0.001); spontaneous echo contrast (12%) with advanced age (p < 0.01), constant atrial fibrillation (p < 0.01), hypertension (p < 0.01), heart failure (p < 0.05), valvular abnormalities (p < 0.01) and large left atrial diameter (p < 0.01), and large left atrial appendages with constant atrial fibrillation (p < 0.05), diabetes (p < 0.05) and valvular abnormalities (p < 0.05).
Related collections
Author and article information
Journal
Article
176923 Cardiology 1995;86:457–463Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.